CORRELATION FINDINGS AND FREQUENCY OF CALR EXON 9 MUTATIONS IN WILD TYPE JAK2 BCR-ABL-NEGATIVE MPN PATIENTS

被引：0

作者：

Limsuwanachot, Nittaya ^{[1
]}

Rerkamnuaychoke, Budsaba ^{[1
]}

Chareonsirisuthigul, Takol ^{[1
]}

Chancharunee, Suporn ^{[2
]}

Siriboonpiputtana, Teerapong ^{[1
]}

机构：

[1] Human Genet Lab, Bangkok, Thailand

[2] Ramathibodi Hosp, Div Hematol, Bangkok, Thailand

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2016年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 64

页数：1

共 50 条

[1] Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients
Limsuwanachot, N.
Rerkamnuaychoke, B.
Chuncharunee, S.
Pauwilai, T.
Singdong, R.
Rujirachaivej, P.
Chareonsirisuthigul, T.
Siriboonpiputtana, T.
HEMATOLOGY, 2017, 22 (10) : 599 - 606
[2] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
Dayyeni, Aseel M. Al
Al-Gailani, Bassam T.
Mahdi, Mohammed Ghanim
Khazeem, Mushtaq M.
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
[3] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
Dayyeni, Aseel M. Al
Al-Gailani, Bassam T.
Mahdi, Mohammed Ghanim
Khazeem, Mushtaq M.
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
[4] The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms
Lin, Yani
Liu, Enbin
Sun, Qi
Ma, Jiao
Li, QingHua
Cao, Zeng
Wang, Jun
Jia, Yujiao
Zhang, Hongju
Song, Zhen
Ai, Xiaofei
Shi, Lihui
Feng, Xiaofang
Li, Chenwei
Wang, Jianxiang
Ru, Kun
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (01) : 165 - 171
[5] CALR, JAK2 Exon 14, and JAK2 Exon 12 mutations profiles in patients with Myeloproliferative Neoplasms
Yasin, Elrashed B.
Alkhatabi, Heba
Ahmedah, Hanadi Talal
Felimban, Raed
Tayeb, Hossam H.
Alalla, Zainab Jawdat
Abdulqayoom, Heyam Abdulsamad
Alserihi, Raed
BIOSCIENCE RESEARCH, 2021, 18 (02): : 1699 - 1707
[6] THE FREQUENCY AND PROGNOSTIC OF EZH2 MUTATIONS IN PATIENTS WITH BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Polushkina, L.
Martynkevich, I.
Petrova, E.
Martynenko, L.
Cybakova, N.
Petrova, M.
Shabanova, E.
Zotova, I.
Zamotina, T.
Fominykh, M.
Shuvaev, V.
Abdulkadyrov, K.
HAEMATOLOGICA, 2014, 99 : 660 - 660
[7] JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms
Giraldo-Rincon, Ana Isabel
Molina, Sara Naranjo
Gomez-Lopera, Natalia
Acevedo, Daniel Aguirre
Benavidez, Andrea Ucroz
Cardenas, Kenny Galvez
Ambrosi, Francisco Cuellar
Torres, Jose Domingo
Ospina, Sigifredo
Palacio, Katherine
Jaramillo, Lina Gaviria
Muneton, Carlos Mario
Palacio, Gonzalo Vasquez
COLOMBIA MEDICA, 2023, 54 (03):
[8] FREQUENCY OF CONCURRENT BCR-ABL1, JAK2, CALR AND MPL MUTATIONS IN A COHORT OF 5,545 CASES WITH SUSPECTED MPN BY A DEEP SEQUENCING APPROACH
Jeromin, S.
Meggendorfer, M.
Fasan, A.
Haferlach, C.
Kern, W.
Haferlach, T.
HAEMATOLOGICA, 2017, 102 : 538 - 538
[9] Allogeneic Stem Cell Transplantation in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms Pretreated with JAK1/JAK2 Inhibitors
Barabanshikova, Maria
Morozova, Elena
Moiseev, Ivan
Vlasova, Julia
Baykov, Vadim
Ushal, Inna
Rodionov, Gennadij
Moiseev, Sergey
Barkhatov, Ildar
Afanasyeva, Ksenija
Bondarenko, Sergey
Afanasyev, Boris
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 402 - 403
[10] Frequency of JAK2 exon 12 mutations in JAK2 exon 14 V617F-negative patients: High frequency in ET patients
Duke, Veronique M.
Gurunlian, Nicole
Yogashangari, Bi
Colley, Tom
McNamara, Christopher
Hoffbrand, A. Victor
Foroni, Letizia
BLOOD, 2007, 110 (11) : 748A - 748A

← 1 2 3 4 5 →